58 related articles for article (PubMed ID: 2198584)
1. Antibodies to liposomes, phospholipids, and cholesterol: implications for autoimmunity, atherosclerosis, and aging.
Alving CR
Prog Clin Biol Res; 1990; 343():41-51. PubMed ID: 2198584
[No Abstract] [Full Text] [Related]
2. Antibodies to cholesterol, cholesterol conjugates and liposomes: implications for atherosclerosis and autoimmunity.
Alving CR; Swartz GM
Crit Rev Immunol; 1991; 10(5):441-53. PubMed ID: 2021426
[TBL] [Abstract][Full Text] [Related]
3. HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies.
Alving CR; Beck Z; Karasavva N; Matyas GR; Rao M
Mol Membr Biol; 2006; 23(6):453-65. PubMed ID: 17127618
[TBL] [Abstract][Full Text] [Related]
4. Interactions of gamma-immunoglobulins with lipid mono- or bilayers and liposomes. Existence of two conformations of gamma-immunoglobulins of different hydrophobicities.
Vandenbranden M; de Coen JL; Jeener R; Kanarek L; Ruyschaert JM
Mol Immunol; 1981 Jul; 18(7):621-31. PubMed ID: 7300838
[No Abstract] [Full Text] [Related]
5. Enhancement of immunogenicity of tumour virus antigen by liposomes: the effect of lipid composition.
Bakouche O; Gerlier D
Immunology; 1986 Jul; 58(3):507-13. PubMed ID: 3733150
[TBL] [Abstract][Full Text] [Related]
6. Lipid A and liposomes containing lipid A as antigens and adjuvants.
Alving CR; Rao M
Vaccine; 2008 Jun; 26(24):3036-45. PubMed ID: 18226433
[TBL] [Abstract][Full Text] [Related]
7. Antibodies reactive with liposomal phospholipids are produced during experimental Trypanosoma rhodesiense infections in rabbits.
Richards RL; Aronson J; Schoenbechler M; Diggs CL; Alving CR
J Immunol; 1983 Mar; 130(3):1390-4. PubMed ID: 6185580
[TBL] [Abstract][Full Text] [Related]
8. Liposomes can function as targets for natural killer cytotoxic factor but not for tumor necrosis factor.
Roozemond RC; Urli DC; Jansen J; Bonavida B
J Immunol; 1989 Feb; 142(4):1209-16. PubMed ID: 2915117
[TBL] [Abstract][Full Text] [Related]
9. Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens.
Alving CR
Biochim Biophys Acta; 1992 Dec; 1113(3-4):307-22. PubMed ID: 1450204
[No Abstract] [Full Text] [Related]
10. Antibodies to lipids and liposomes: immunology and safety.
Alving CR
J Liposome Res; 2006; 16(3):157-66. PubMed ID: 16952870
[TBL] [Abstract][Full Text] [Related]
11. Re-incorporation of the terminal C5b-9 complement complex into lipid bilayers: formation and stability of reconstituted liposomes.
Bhakdi S; Tranum-Jensen J
Immunology; 1980 Nov; 41(3):737-42. PubMed ID: 7461711
[TBL] [Abstract][Full Text] [Related]
12. Assess the nature of cholesterol-lipid interactions through the chemical potential of cholesterol in phosphatidylcholine bilayers.
Ali MR; Cheng KH; Huang J
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5372-7. PubMed ID: 17372226
[TBL] [Abstract][Full Text] [Related]
13. Characterization of immunogenic properties of haptenated liposomal model membranes in mice. V. Effect of membrane composition on humoral and cellular immunogenicity.
van Houte AJ; Snippe H; Schmitz MG; Willers JM
Immunology; 1981 Nov; 44(3):561-8. PubMed ID: 7033115
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharides in bacterial membranes act like cholesterol in eukaryotic plasma membranes in providing protection against melittin-induced bilayer lysis.
Allende D; McIntosh TJ
Biochemistry; 2003 Feb; 42(4):1101-8. PubMed ID: 12549932
[TBL] [Abstract][Full Text] [Related]
15. Antibodies induced by liposomal protein exhibit dual binding to protein and lipid epitopes.
Karasavvas N; Beck Z; Tong J; Matyas GR; Rao M; McCutchan FE; Michael NL; Alving CR
Biochem Biophys Res Commun; 2008 Feb; 366(4):982-7. PubMed ID: 18088597
[TBL] [Abstract][Full Text] [Related]
16. Development of non-phospholipid liposomes containing a high cholesterol concentration.
Bastiat G; Oliger P; Karlsson G; Edwards K; Lafleur M
Langmuir; 2007 Jul; 23(14):7695-9. PubMed ID: 17564471
[TBL] [Abstract][Full Text] [Related]
17. Transbilayer complementarity of phospholipids in cholesterol-rich membranes.
Zhang J; Jing B; Tokutake N; Regen SL
Biochemistry; 2005 Mar; 44(9):3598-603. PubMed ID: 15736969
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to cholesterol: biological implications of antibodies to lipids.
Alving CR; Wassef NM; Potter M
Curr Top Microbiol Immunol; 1996; 210():181-6. PubMed ID: 8565556
[TBL] [Abstract][Full Text] [Related]
19. Complement activation in rats by liposomes and liposome-encapsulated hemoglobin: evidence for anti-lipid antibodies and alternative pathway activation.
Szebeni J; Wassef NM; Spielberg H; Rudolph AS; Alving CR
Biochem Biophys Res Commun; 1994 Nov; 205(1):255-63. PubMed ID: 7999033
[TBL] [Abstract][Full Text] [Related]
20. Do antibodies to phospholipid antigens play any role in murine leprosy?
Rojas-Espinosa O; Wek Rodriguez K; Vargas Hernandez JA; Arce Paredes P
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):453-9. PubMed ID: 10700921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
